Table 1.

Demographic characteristics of focus group participants (N = 33)

		N (%)
Age (years)
	Mean	57
	Standard deviation (SD)	11.35
Gender
	Male	6 (18.2%)
	Female	27 (81.8%)
Education*
	Some high school	2 (6.1%)
	Graduated from high school	4 (12.1%)
	GED certificate	3 (9.1%)
	Vocational school	1 (3.0%)
	Some college	11 (33.3%)
	Graduate from college	6 (18.2%)
	Graduate degree	5 (15.2%)
Cancer stage
	Early (stage 1 and stage 2)	18 (54.5%)
	Late (stage 3 and stage 4)	11 (33.3%)
	Unsure	4 (12.1%)
Insurance**
	Private/commercial	6 (18.2%)
	Medicare or Medicaid	13 (39.4%)
	Multiple insurance coverage	10 (30.3%)
	Not sure	1 (3.0%)
	Other	3 (9.1%)
Income
	Less than $10,000	6 (18.2%)
	$10,000 to $19,999	4 (12.1%)
	$20,000 to $29,000	6 (18.2%)
	$30,000 to $49,999	5 (15.2%)
	$50,000 to $74,999	2 (6.1%)
	$75,000 or more	4 (12.1%)
	Don’t know/not sure	5 (15.2%)
Have you ever had a TGP test done as part of your cancer treatment
	Yes	7 (21.2%)
	No	13 (39.4%)
	Not sure	13 (39.4%)
Have you ever heard about Tumor Genetic Profiling tests (TGP) from a doctor or other healthcare provider?
	Yes	18 (54.5%)
	No	11 (33.3%)
	Not sure	4 (12.1%)
Which statement best describes the way you like to make treatment decisions?
	I prefer to make the final selection about which treatment I will receive	5 (15.2%)
	I prefer to make the final selection of my treatment after seriously considering my doctor’s opinion	9 (27.3%)
	I prefer that my doctor and I share responsibility for deciding which treatment is best for me	11 (33.3%)
	I prefer that my doctor makes the final decision about which treatment will be used, but seriously consider my opinion	4 (12.1%)
	I prefer to leave all decisions regarding my treatment to my doctor	4 (12.1%)

N = 1 missing demographic survey

*M(SD)

**N= 1 missing